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a b s t r a c t
During persistent infection of HCV, the HCV core protein (HCV-JFH-1 strain of genotype 2a) is recruited
to lipid droplets (LDs) for viral assembly, but the mechanism of recruitment of the HCV core protein is
uncertain. Here, we demonstrated that one of the Ras-related small GTPases, Rab18, was required for
trafﬁcking of the core protein around LDs. The knockdown of Rab18 reduced intracellular and
extracellular viral infectivity, but not intracellular viral replication in HCV-JFH-1-infected RSc cells (an
HuH-7-derived cell line). Exogenous expression of Rab18 increased extracellular viral infectivity almost
two-fold. Furthermore, Rab18 was co-localized with the core protein in HCV-JFH-1-infected RSc cells,
and the knockdown of Rab18 blocked recruitment of the HCV-JFH-1 core protein to LDs. These results
suggest that Rab18 has an important role in viral assembly through the trafﬁcking of the core protein
to LDs.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Hepatitis C virus (HCV) is an enveloped positive single-
stranded RNA virus belonging to the Flaviviridae family (Choo
et al., 1989). The HCV genome encodes a large polyprotein
precursor of approximately 3000 amino acid (aa) residues, which
is cleaved co- and post-translationally into at least ten proteins in
the following order: core, envelope 1 (E1), E2, p7, nonstructural
protein 2 (NS2), NS3, NS4A, NS4B, NS5A, and NS5B (Kato, 2001).
Persistent HCV infection in the liver causes chronic hepatitis, and
then highly progresses to liver cirrhosis and hepatocellular carci-
noma (Ohkoshi et al., 1990). Therefore, the elimination of HCV RNA
by the anti-HCV reagents such as interferon is necessary to block
the progression of liver diseases such as liver cirrhosis and
hepatocellular carcinoma. To date, the HCV-JFH-1 strain (genotype
2a) has mainly been used to study the complete life cycle of HCV
worldwide. In HCV-JFH-1-infected human hepatoma HuH-7 cells,
viral replication intermediate, double-stranded RNA, is detected
adjacent to the membranes of the endoplasmic reticulum (ER)
(Targett-Adams et al., 2008). In addition, the HCV replication
complex is formed on a detergent-resistant membrane (Shi et al.,
2003). These results suggest that HCV RNA replication occurs on
lipid rafts and the membranous web at the cytosolic side of the ER.
Following viral replication, the HCV core protein matures through
the translation of a large polyprotein precursor from HCV RNA and
then the processing by signal peptide peptidase. The matured
HCV-JFH-1 core protein has been shown to be trafﬁcked to lipid
droplets (LDs) for viral assembly (Miyanari et al., 2007).
LDs are important organelles for lipid metabolism. LDs are
covered by a phospholipid monolayer, and accumulate excessive
neutral lipids such as triglycerides. A proteomics analysis revealed
that a number of host factors are associated with LDs (Brasaemle
et al., 2004). These host factors are required for acquisition, storage,
lipolysis, transport and/or release of lipids, respectively. The ﬁrst of
these LD-associated factors to be identiﬁed were members of the
PAT family of proteins, including perilipin (PLIN), ADRP (adipose
differentiation-related protein; also named adipophilin or PLIN2),
and TIP47 (also named PLIN3). PLIN is expressed only in adipocytes
and steroidogenic cells, whereas ADRP and TIP47 are expressed in
various cell types. ADRP and TIP47 have similar sequences and
three-dimensional structures (Hickenbottom et al., 2004), but their
intracellular distributions in HuH-7 cells are different (Ohsaki et al.,
2006). ADRP localizes exclusively to the surface of LDs in HuH-7
cells, whereas only some of total TIP47 localizes to the LD surface in
this cell line. During viral assembly, the core protein is trafﬁcked to
ADRP on LDs (Counihan et al., 2011). ADRP is displaced from the
surface of LDs to the cytoplasm by the core protein, and then
subjected to degradation (Boulant et al., 2008). These displacements
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of ADRP also cause the redistribution of LDs around the nucleus
(Boulant et al., 2008). These observations imply that the core
protein may increase the probability of an interaction between
the sites of viral replication at the ER and viral assembly at the LDs.
However, the precise mechanism of intracellular trafﬁcking of the
core protein to ADRP on LDs is still uncertain.
A family of Ras-related small GTPases plays an important role in
the membrane trafﬁcking between organelles such as the ER, Golgi,
early/late endosomes, LDs, and so on (Hutagalung and Novick, 2011).
One of the Ras-related small GTPases, Rab18, is required for membrane
trafﬁcking between the ER and Golgi (Dejgaard et al., 2008). On the
other hand, Rab18 is an LD-associated protein, and the ectopic
expression of Rab18 induces the close apposition of LDs to ER
membranes through the reduction of ADRP (Ozeki et al., 2005). These
observations imply that Rab18 may be required for membrane
trafﬁcking through the redistribution of LDs around the ER. Recently,
Salloum et al. reported that Rab18 bound HCV-JFH-1 NS5A and may
have promoted the interaction between sites of viral replication and
LDs in HCV-Jc1-infected Huh7.5.1 cells (Salloum et al., 2013). However,
HCV-Jc1 is an intragenotypic recombinant encoding core to NS2 from
the HCV-J6 strain (genotype 2a) in the context of HCV-JFH-1, and does
not exist in nature. In addition, although HCV-Jc1 was shown to be
more robust in the release of viral particles than HCV-JFH-1, the HCV-
J6 core protein did not associate with LDs (Shavinskaya et al., 2007).
On the other hand, the HCV-JFH-1 core protein does associate with
LDs, and LD-associated core proteins recruit HCV NS protein from the
ER to LDs (Miyanari et al., 2007). These results imply that HCV-Jc1 may
release viral particles via an intracellular organelle distinct from the
LDs. Therefore, we hypothesized that Rab18 ﬁrst trafﬁcked the
HCV-JFH-1 core protein and subsequently NS5A to LD. To prove
this hypothesis, we examined the association of the HCV-JFH-1 core
protein with LDs and the levels of viral assembly in Rab18-
knockdown cells.
Here, we show that Rab18 is required for trafﬁcking of the HCV-
JFH-1 core protein to LDs and the subsequent assembly of HCV.
Rab18 may be involved in the maturation of viral particles through
membrane trafﬁcking of the HCV-JFH-1 core protein from the sites
of viral replication at the ER to viral assembly at the LDs in human
hepatocytes.
Results
RSc cells show higher viral productivity than Huh7.5 cells
To date, human hepatoma HuH-7 cells have mainly been used
to study the complete life cycle of HCV in studies worldwide. One
of the sublines of HuH-7 cells, Huh7.5, is used in many laboratories
for its high susceptibility to infection with the HCV-JFH-1 strain
(genotype 2a). On the other hand, we have previously established
several types of HCV RNA-replicating cells (genotype 1b, O strain),
such as sO cells (Kato et al., 2003, sub-genomic HCV RNA), O cells
(Ikeda et al., 2005, genome-length HCV RNA), and OR6 cells (Ikeda
et al., 2006, genome-length HCV RNA-encoding renilla luciferase)
derived from HuH-7 cells, and their “cured” cells (sOc (Kato et al.,
2003), Oc (Ikeda et al., 2005), OR6c (Ikeda et al., 2006), respec-
tively) by the elimination of HCV RNA (Fig. 1A). The cured cell lines
have been reported to increase the permissiveness of HCV (Blight
et al., 2002). We also previously reported that Oc cells showed
higher permissiveness of HCV than sOc cells (Abe et al., 2007). RSc
cells are one of our cured cell lines derive from OR6c cells, and
have mainly been used to study the complete life cycle of HCV in
our laboratory (Ariumi et al., 2007, 2008; Kato et al., 2009).
However, we have no information on viral susceptibility of our
cured cell lines to HCV-JFH-1 infection. To identify which of
our cured cell lines would be most useful for the infection with
HCV-JFH-1, we ﬁrst compared the amounts of LDs by two
methods, i.e., a confocal microscope and ﬂow cytometry. The LDs
were stained with BODIPY493/503 and observed under a confocal
microscope. In our cured cells (sOc, Oc, OR6c, and RSc cells), the
numbers rather than the sizes of LDs have increased compared to
HuH-7 cells (Fig. 1B). In addition, the mean ﬂuorescence intensity
of BODIPY493/503-stained cells has increased by the enhance-
ments of the numbers of LDs (Fig. 1C). These qualitative and
quantitative analyses revealed that our cured cells (sOc, Oc, OR6c,
and RSc cells) formed higher levels of LDs than HuH-7 and Huh7.5
cells (Fig. 1B and C). Interestingly, irrespective of the quantitative
difference of LDs, the levels of viral replication at 72 h after the
viral inoculation of HCV-JFH-1 were comparable between each of
our cured cell lines and Huh7.5 cells, but not between each of the
cured cell lines and HuH-7 cells (Fig. 1D). Moreover, the time-
course analysis showed that the capacities of HCV RNA replication
were almost comparable between RSc and Huh7.5 cells (Fig. 1E).
These results suggest that the levels of HCV RNA replication do not
depend on the amount of LDs. Next, to compare the levels of viral
assembly and viral productivity between RSc and Huh7.5 cells, we
examined the infectivity of the cell lysates (intracellular infectiv-
ity) and the supernatants (extracellular infectivity) derived from
both lines of HCV-JFH-1-infected cells. The intracellular and
extracellular infectivities of HCV-JFH-1-infected RSc cells were
signiﬁcantly higher than those of HCV-JFH-1-infected Huh7.5 cells
(Fig. 1F). These results suggest that RSc cells possess higher viral
productivity in response to infection with HCV-JFH-1 than
Huh7.5 cells.
Rab18 is required for viral production, but not viral RNA replication
As the ﬁrst step of viral assembly, the HCV-JFH-1 core protein
displaces ADRP from the surface of LDs to the cytoplasm (Boulant
et al., 2008; Counihan et al., 2011). In the present study, we tried to
clarify how the core protein is trafﬁcked to LDs by using RSc
and Huh7.5 cells. It has been reported that Rab18, one of the
Ras-related small GTPase family members, induces the close apposi-
tion of LDs to ER membranes through the reduction of ADRP (Ozeki et
al., 2005). Based on these previous ﬁndings, we hypothesized that
Rab18 is required for trafﬁcking of the HCV-JFH-1 core protein to LDs.
To prove this hypothesis, we ﬁrst examined the expression levels of
Rab18 in RSc and Huh7.5 cells. The expression levels of Rab18 were
almost comparable between RSc cells and Huh7.5 cells at both the
transcript (Fig. 2A) and protein levels (Fig. 2B). Two other members of
the Ras-related small GTPases, Rab5 and Rab7, were also present at
almost the same levels in RSc and Huh7.5 cells. We next examined the
effect of the knockdown of Rab18 against HCV replication in RSc cells.
The knockdown of Rab18 (Fig. 2C) had no effect on the RNA replication
step (Fig. 2D). Rab18-knockdown Huh7.5 cells and genome-length
HCV RNA-replicating O cells (Kato et al., 2009) also showed similar
results (Fig. 2E and F, Supplemental Fig. S1A and B). However, we
found that the knockdown of Rab18 caused a signiﬁcant decrease in
viral productivity in both RSc and Huh7.5 cells (Fig. 2G). In addition,
the knockdown of ADRP (Supplemental Fig. S2A) also decreased viral
productivity rather than HCV RNA replication (Supplemental Fig. S2B).
Furthermore, we demonstrated that the overexpression of Rab18
(Fig. 2H) recovered the viral productivity (Fig. 2I) rather than viral
RNA replication (Fig. 2J). From these results, we conclude that Rab18 is
required for viral production of HCV.
Rab18 is required for viral assembly through the trafﬁcking of the
HCV-JFH-1 core protein to LDs
To clarify whether Rab18 is required for the viral assembly step,
we ﬁrst examined the localization of Rab18 and the HCV core
protein in HCV-JFH-1-infected cells. The results revealed that Rab18
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Fig. 1. RSc cells possess higher viral productivity in response to the infection with HCV-JFH-1 than Huh7.5 cells. (A) Outline for the establishment of our HCV RNA-replicating
cells and their “cured” cells. Our HCV RNA-replicating cells (sO, O, and OR6 cells) are independently established by the transfection of HCV RNA into HuH-7 or cured cells (sOc
or Oc cells) as previously reported (Ikeda et al., 2005, 2006; Kato et al., 2003). To prepare the cured cells, HCV RNA was eliminated from HCV RNA-replicating cells by the
interferon treatment. RSc cells are one of the sublines of OR6c cells. The arrows with solid and dashed lines show the transfection of HCV RNA and the interferon treatment,
respectively. (B) Visualization of LD under a confocal microscope. The panels show the ﬂuorescence of LD by staining with BODIPY493/503. Bars, 20 μm. (C) Measurement of
the mean ﬂuorescence intensity of BODIPY493/503-stained cells by a ﬂow cytometer. These levels were calculated relative to the level in HuH-7 cells, which was set at 1.
(D) Quantitative RT-PCR analysis of HCV RNA in our cured cells 72 h after infection with HCV-JFH-1. Total RNA extracted from the cells was subjected to quantitative RT-PCR
analysis. The experiments were performed in at least triplicate. (E) Time-course analysis of HCV RNA in RSc and Huh7.5 cells after infection with HCV-JFH-1. Total RNA was
extracted from HCV-JFH-1-infected cells at each time point. (F) Quantitative RT-PCR analysis of HCV RNA in Huh7.5 cells 72 h after infection with intracellular (left panel) and
extracellular (right panel) HCV-JFH-1. As intracellular or extracellular HCV-JFH-1, the lysate or the supernatant was recovered from RSc cells (designated J-RSc in the ﬁgure)
and Huh7.5 cells (designated J-Huh7.5) 24 h after infection with HCV-JFH-1.
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was co-localized with the core protein in HCV-JFH-1-infected RSc
and Huh7.5 cells (Fig. 3A). We previously reported that the core
protein was not recruited to LDs in O cells, fromwhich no infectious
virus was produced (data not shown). In fact, in contrast to HCV-
JFH-1-infected RSc and Huh7.5 cells, co-localization of Rab18 and
the core protein was not observed in O cells (Fig. 3B), although the
expression of Rab18 were almost comparable levels among these
cell lines (Supplemental Fig. S1C). We next examined the infectivity
of intracellular viral particles in HCV-JFH-1-infected RSc siRab18
cells. The results revealed that the knockdown of Rab18 inhibited
90% of the production of intracellular viral particles (Fig. 3C) and the
recruitment of the core protein to LDs (Fig. 3D). However, the
knockdown of Rab4 (early endosome marker), other Ras-related
small GTPase family member, inhibited only 40% of the production
of intracellular viral particles (Supplemental Fig. S3C). These results
suggest that Rab18 is particularly required for viral assembly
through the trafﬁcking of the core protein to LDs. Rab18 may be
involved in the maturation of viral particles through membrane
trafﬁcking of the core protein from the ER to LDs.
Discussion
Previous proteomics analysis showed that a number of host
factors were associated with LDs (Brasaemle et al., 2004). These
LD-associated proteins may be required for the life cycle of HCV as
well as the metabolism of lipids. During viral production, the HCV
core protein is recruited to LDs in HCV-JFH-1-infected cells
(Miyanari et al., 2007). In the present study, we suggest that one
of the LD-associated proteins, Rab18, is required for trafﬁcking of
the HCV core protein to LDs and subsequent viral assembly.
The HCV core protein consists of three domains (domains 1, 2,
and 3). Domain 2 (aa 118–173) contains two proline residues at aa
positions 138 and 143, and a YATG sequence ranging from aa
positions 164–167 that is essential for the association with LDs
(Hope et al., 2002). These are conserved in both the JFH-1 strain
(genotype 2a) and O strain (genotype 1b). However, the core
protein was associated with LDs in HCV-JFH-1-infected RSc cells
(Fig. 3D), but not in genome-length HCV RNA-replicating O cells
(Kato et al., 2009). Matto et al. found that there were two
morphologically distinct populations of the core protein (the
ring-like and the dot-like pattern) in genome-length HCV RNA
(genotype 1b)-replicating cells (Matto et al., 2004). The ring-like
core protein was associated with LDs, and the dot-like core protein
was associated with the detergent-resistant membranes and the
lipid rafts essential for viral replication (Matto et al., 2004). We
previously demonstrated that the core protein of the O strain
showed a dot-like pattern (Kato et al., 2009), and that infectious
virus was not produced from O cells (data not shown). In contrast
to the core protein of the JFH-1 strain, the core protein of the O
strain was not trafﬁcked to LDs, and may have remained at the
detergent-resistant membranes and the lipid rafts.
We also demonstrated that the core protein was co-localized
with Rab18 in HCV-JFH-1-infected RSc cells, but not in O cells
(Fig. 3B). In addition, we demonstrated that the knockdown of
Rab18 did not inhibit HCV RNA replication in O cells as well as
HCV-JFH-1-infected RSc cells (Supplemental Figs. S1,B and S3B).
However, in contrast to our results, Salloum et al. have previously
observed that the knockdown of Rab18 inhibited HCV RNA
replication in OR6 cells (Salloum et al., 2013). From these results,
we speculate the clonality of HuH-7 cells as one of causes of this
discrepancy. On the other hand, it also remains the possibility that
the induction of IFN-β by shRNA reduced HCV RNA replication.
Kenworthy et al. has previously reported that the introduction of
shRNA by lentiviral vector may induce IFN-β (Kenworthy et al.,
2009). Rab18 knockdown cells in the Salloum's paper were
generated by the introduction of shRNA using lentiviral vector. In
addition, Rab18 overexpression did not enhance HCV RNA replica-
tion in OR6 cells (Salloum et al., 2013). Another proteomic analysis
suggested that Rab18 is upregulated in the lipid raft fraction of
Fig. 1. (continued)
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Fig. 2. Rab18 is required for viral production, but not viral RNA replication. (A) Quantitative RT-PCR analysis of Rab18, Rab5, and Rab7 mRNA in RSc and Huh7.5 cells. These levels
were calculated relative to the level in RSc cells, which was set at 1. (B) Western blot analysis of Rab18, Rab5, and Rab7 in RSc and Huh7.5 cells. β-actin was included as a loading
control. (C) Western blot analysis of Rab18 expression in RSc cells transfected with Rab18-speciﬁc (designated RSc siRab18 in the ﬁgure) or control (designated RSc siCont) siRNA.
Cell lysates were prepared from RSc cells 120 h after transfection with Rab18-speciﬁc or control siRNA. (D) Quantitative RT-PCR analysis of HCV RNA in RSc siRab18 cells 24 h after
infection with HCV-JFH-1. Transfection was performed 96 h before infection with HCV-JFH-1. NS: no signiﬁcance. (E) Western blot analysis of Rab18 expression in Huh7.5 cells
transfected with Rab18-speciﬁc (designated Huh7.5 siRab18) or control (designated Huh7.5 siCont) siRNA. (F) Quantitative RT-PCR analysis of HCV RNA in Huh7.5 siRab18 and
siCont cells 24 h after infection with HCV-JFH-1. (G) Quantitative RT-PCR analysis of HCV RNA in Huh7.5 cells 72 h after infection with extracellular HCV-JFH-1. (Left panel)
As extracellular HCV-JFH-1, the supernatant was recovered from RSc siCont cells (designated J-RSc siCont) or RSc siRab18 cells (designated J-RSc siRab18) 24 h after infection with
HCV-JFH-1. (Right panel) The supernatant was also recovered from Huh7.5 siRab18 cells (designated J-Huh7.5 siRab18) and Huh7.5 siCont cells (designated J-Huh7.5 siCont) 24 h
after infection with HCV-JFH-1. (H) Western blot analysis of Rab18 expression in Huh7.5 cells stably expressing Myc-tagged Rab18 (designated Huh7.5 Myc-Rab18). The arrow and
arrowhead indicate exogenous (Myc-tagged) and endogenous Rab18, respectively. (I) Quantitative RT-PCR analysis of HCV RNA in Huh7.5 cells 72 h after infection with extracellular
HCV-JFH-1. As extracellular HCV-JFH-1, the supernatant was recovered from Huh7.5 Cont (designated J-Huh7.5 Cont) or Huh7.5 Myc-Rab18 (designated J-Huh7.5 Myc-Rab18) 24 h
after infection with HCV-JFH-1. (J) Quantitative RT-PCR analysis of HCV RNA in Huh7.5 Myc-Rab18 cells 24 h after infection with HCV-JFH-1.
genome-length HCV RNA (genotype 1b)-replicating cells
(Mannova et al., 2006). These results may suggest that Rab18 also
remained at the detergent-resistant membranes and the lipid rafts
in the genome-length HCV RNA (genotype 1b)-replicating cells
such as O cells. In addition, the gene silencing of Rab18 (Rab18-
knockdown JFH-1-infected RSc cells) blocked localization of the
HCV-JFH-1 core protein to LDs (Fig. 3D). Interestingly, the morphol-
ogy of the population of HCV-JFH-1 core proteins was changed from a
ring-like pattern to a dot-like pattern by the gene silencing of Rab18
(Fig. 3D). The HCV replication complex is formed on detergent-
resistant membranes of the ER lumen (Shi et al., 2003). The ectopic
expression of Rab18 induces the close apposition of LD to ER
membranes through the reduction of ADRP (Ozeki et al., 2005).
Rab18 may be one of the key host factors for the switch from the
viral replication step to the viral assembly step through the close
apposition of the detergent-resistant membranes to LDs. Rab18 may
be an important target for the development of more effective anti-HCV
reagents.
Materials and methods
Cell culture, reagents, and plasmids
Human hepatoma Huh7.5 cells were provided by Apath LLC
(Brooklyn, NY). Huh7.5 cells, HuH-7 cells, and our established
HuH-7-derived cells (sOC, Oc, OR6c, and RSc cells) were cultured
in Dulbecco's modiﬁed Eagle's medium (Invitrogen, Carlsbad, CA)
supplemented with 10% fetal bovine serum. Blasticidin (2 μg/ml)
was used for the selection of Huh7.5 cells exogenously expressing
Myc-Rab18. G418 (0.3 mg/ml) was also used for the selection of
genome-length HCV RNA-replicating O cells.
Fig. 3. Rab18 is required for viral assembly through the trafﬁcking of HCV-JFH-1 core protein on LDs. (A) Visualization of the HCV-JFH-1 core protein (red) and Rab18 (green)
under a confocal microscope. The panels show RSc or Huh7.5 cells 72 h after infection with HCV-JFH-1. Bars, 10 μm. (B) Visualization of the core protein (red) and Rab18
(green) in O cells. Bars, 10 μm. (C) Quantitative RT-PCR analysis of HCV RNA in Huh7.5 cells 72 h after infection with intracellular HCV-JFH-1. As intracellular HCV-JFH-1, the
lysate was prepared from RSc siRab18 cells (designated J-RSc siRab18) and RSc siCont cells (designated J-RSc siCont) 24 h after infection with HCV-JFH-1. (D) Visualization of
the HCV-JFH-1 core protein (red) and LD (green) under a confocal microscope. The panels show RSc siRab18 and siCont cells 72 h after infection with HCV-JFH-1. Bars, 10 μm.
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Immunoﬂuorescence analysis
The LDs were stained with BODIPY493/503 (Invitrogen), and
then photographed under a confocal microscope. Anti-Core anti-
body (CP11; Institute of Immunology, Tokyo, Japan) and anti-
Rab18 antibody (Sigma, St. Louis, MO) were used as the primary
antibodies. AlexaFluor 488-conjugated goat anti-rabbit antibody
and AlexaFluor 594-conjugated goat anti-mouse antibody (Invi-
trogen) were used as the secondary antibodies. The intracellular
localizations of HCV core protein and Rab18 were visualized and
photographed under a confocal microscope as previously reported
(Dansako et al., 2008). 40-6-diamino-2-phenylindole (DAPI; Sigma)
was used for visualization of the nucleus.
Flow cytometric analysis
The LDs were stained with BODIPY493/503 and then their
mean ﬂuorescence intensity was measured by a ﬂow cytometer.
The levels of LDs were calculated relative to the level in HuH-7
cells, which was set at 1.
Infection with HCV-JFH-1
The cells were infected with HCV-JFH1 (genotype 2a) for the
appropriate time at a multiplicity of infection (MOI) of 1, and then
the samples were prepared for the Western blot analysis, immu-
noﬂuorescence analysis, and quantitative reverse transcription
(RT)-PCR. Cell lysates and supernatants were prepared from the
HCV-JFH-1-infected cells to monitor intracellular and extracellular
infectivity. Intracellular HCV-JFH-1 was prepared from HCV-JFH-1-
infected cells by repeated freeze-thaw cycles.
Generation of Rab18-knockdown cells
Small interfering RNAs (siRNAs) targeting Rab18 (Thermo Scientiﬁc;
M-010824-00-0005) were prepared to generate Rab18-knockdown
cells. siRNAs targeting Rab18 or non-targeting siRNAs (Thermo
Scientiﬁc; D-001206-13-20) were introduced into RSc or Huh7.5
cells by DharmaFECT transfection reagent (Thermo Fisher Scien-
tiﬁc, Waltham, MA). After transfection for the appropriate amount
of time, Rab18-knockdown cells were infected with HCV-JFH-1.
Quantitative RT-PCR analysis
Total cellular RNA was isolated from HCV-JFH-1-infected cells by
using an RNeasy mini kit (Qiagen, Hilden, Germany). RT was
performed as previously described (Dansako et al., 2009). A SYBR
Premix Ex Taq kit (TaKaRa Bio, Otsu, Japan) was used to measure the
RNA levels of Rab18, Rab5, Rab7, GAPDH, or HCV. We used the
following forward and reverse primer sets for quantitative PCR: for
Rab18, 50-GCGGAACGGGGTCAGGATGG-30 (forward) and 50-AAGAG
CAGGCTGGACTTGCCC-30 (reverse); for Rab5, 50-GCTTGCTGCGGTCT
CAGGTTTCT-30 (forward) and 50-TGGCCCGTTGGGTCTTGTTGC-30
(reverse); for Rab7, 50-CTCATCCAGGCCAGTCCCCGA-30 (forward) and
50–CCCGCTTTGTGGCCACTTGTC-30 (reverse); for HCV and GAPDH, the
primer sets are given in Dansako et al., 2013 and Dansako et al., 2003,
respectively. The levels of Rab18, Rab5, Rab7, and HCV were normal-
ized to the levels of GAPDH mRNA. The mRNA levels of Rab18,
Rab5, and Rab7 in Huh7.5 cells were calculated relative to the level
in RSc cells, which was set at 1. In vitro-transcribed HCV-JFH-1
RNA was used as the standard to calculate the amount of HCV RNA
in HCV-JFH-1-infected cells. Data are the means7SD from three
independent experiments.
Fig. 3. (continued)
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Western blot analysis
Preparation of cell lysates, and SDS-polyacrylamide gel electro-
phoresis were performed as previously described (Dansako et al.,
2005). Gel was transferred to an Immobilon PVDF membrane
(Millipore, Billerica, MA) by using a semi-dry transfer system:
Horize BLOT 2MR (ATTO, Tokyo, Japan). Anti-Core (CP11; Institute
of Immunology Co.), anti-Myc (PL14; Medical & Biological Labora-
tories, Nagoya, Japan), anti-Rab18 (Sigma), anti-Rab5 (S-19;
Santa Cruz Biotechnology. Santa Cruz, CA), anti-Rab7 (Sigma),
Fig. 3. (continued)
H. Dansako et al. / Virology 462-463 (2014) 166–174 173
and anti-β-actin antibody (AC-15; Sigma) were used in this study
as primary antibodies. HRP-conjugated anti-mouse-IgG or anti-
rabbit-IgG was used in this study as a secondary antibody (Cell
Signaling Technology, Beverly, MA). Immunocomplexes were
detected as previously described (Dansako et al., 2007).
Statistical analysis
Determination of the signiﬁcance of differences among groups
was assessed using the Student's t-test. Po0.05 was considered
statistically signiﬁcant.
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